Eventide Asset Management - ONCOMED PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Eventide Asset Management ownership history of ONCOMED PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$1,465,000
-32.6%
190,0000.0%0.10%
-28.6%
Q3 2016$2,172,000
-7.1%
190,0000.0%0.13%
-7.0%
Q2 2016$2,339,000
+21.8%
190,0000.0%0.14%
+33.6%
Q1 2016$1,921,000
-55.1%
190,0000.0%0.11%
-50.0%
Q4 2015$4,283,000
+75.7%
190,000
+29.3%
0.21%
+50.7%
Q3 2015$2,437,000
+27.3%
146,900
+72.6%
0.14%
+36.5%
Q2 2015$1,915,000
-12.7%
85,1000.0%0.10%
-37.0%
Q1 2015$2,194,000
+90.9%
85,100
+61.2%
0.16%
+32.0%
Q4 2014$1,149,000
+14.9%
52,8000.0%0.12%
-10.7%
Q3 2014$1,000,000
-18.7%
52,8000.0%0.14%
-16.2%
Q2 2014$1,230,000
-30.8%
52,8000.0%0.17%
-39.5%
Q1 2014$1,777,000
+167.6%
52,800
+134.7%
0.28%
+34.6%
Q4 2013$664,00022,5000.20%
Other shareholders

There were no reported owners of ONCOMED PHARMACEUTICALS INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of ONCOMED PHARMACEUTICALS INC shareholders